LUCY NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Innovative Eyewear Inc. · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 0.70 USD
7.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -32.6% below the Trend Line and sits at 2.9% of its 52-week range. The latest completed week returned 7.1%, after a -8.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 20 out of 100
Latest Close 0.70 USD 31 Jul 2026
1W Return 7.1% latest completed week
4W Return -8.3% short-term follow-through
12W Return -32.3% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 30.68% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.1% Latest completed week; four-week move -8.3%. Indicator stack 0/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 30.68% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 42 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -32.6% below the Trend Line and sits at 2.9% of its 52-week range. The latest completed week returned 7.1%, after a -8.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.3% over four weeks, -32.3% over 12 weeks, and -64.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W7.1%
4W-8.3%
12W-32.3%
26W-38.9%
52W-64.1%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.19Latest activity-pressure read.
Pressure change14865.5%Four-week change in activity pressure.
Leadership-52.72Latest relative-leadership reading.
RS change3.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength56/100Blend of value, momentum, and quality. Underlying universe rank 45; rank 1 is best.
Value52/100Relative valuation strength. Underlying universe rank 49; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum52/100Medium-term price momentum. Underlying universe rank 49; rank 1 is best.
Growth52/100Revenue and earnings growth. Underlying universe rank 49; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
17.5%
Gross profit retained from each unit of revenue.
Operating margin
-272.5%
Operating profit retained from revenue.
Free-cash-flow margin
-241.8%
Free cash flow generated from revenue.
Return on invested capital
-150.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
74.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 42 relevant articles.

14 positive · 26 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-69.3%Distance below the 52-week high.
13-week volatility15.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2617 weeks finished lower.
Best week+42.1%Week of 10 Jul.
Worst week-25.6%Week of 17 Jul.
Latest week+7.1%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains4
Flat weeks1
Modest losses9
Sharp losses8
Recent vol15.8%13-week weekly-return volatility.
Base vol10.4%52-week weekly-return volatility.
Up/down split15/35Count of positive and negative weeks in the 52-week window.
Average skew8.6% / -5.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 30.68%

Next-week expectancy is negative with a 30.68% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors52/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 42 relevant articles.

Innovative Eyewear Inc (LUCY) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.70 USD7.1%1.03 USD4.87 USD0.19-52.721.1MOff
24 Jul 20260.65 USD-19.1%1.05 USD4.96 USD0.12-56.581.4MOff
17 Jul 20260.80 USD-25.6%1.07 USD5.06 USD0.14-48.493.7MOff
10 Jul 20261.08 USD42.1%1.09 USD5.17 USD0.11-35.13266.1MOff
3 Jul 20260.76 USD-3.0%1.10 USD5.27 USD0.00-54.42168.2KOff
26 Jun 20260.78 USD-2.0%1.12 USD5.38 USD0.33-53.63378.7KOff
19 Jun 20260.80 USD-8.1%1.15 USD5.49 USD0.76-55.76242.1KOff
12 Jun 20260.87 USD-4.2%1.17 USD5.60 USD1.04-52.70257.5KOff
5 Jun 20260.91 USD-12.7%1.20 USD5.88 USD1.01-50.78307.7KOff
29 May 20261.04 USD2.0%1.22 USD6.12 USD1.10-47.76276.0KOff
22 May 20261.02 USD9.7%1.24 USD6.35 USD0.96-49.01435.3KOff
15 May 20260.93 USD-9.7%1.27 USD6.58 USD0.84-54.27627.2KOff
8 May 20261.03 USD-0.1%1.30 USD6.82 USD0.87-50.86488.0KOff
1 May 20261.03 USD-1.8%1.32 USD7.09 USD0.91-48.87264.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.